NLRP3 and Andersen-Tawil syndrome: Furthermore, dapagliflozin therapy suppressed the generation of serum NLRP3, IL-1β, IL-18 levels and ROS in the vasculature of atherosclerotic aortic lesions, thus reducing the progression of ATS, diminishing macrophage infiltration and improving lesion stability [122].